They are a CRISPR/Cas genome editing company that has licensed two patents regarding non-GMO ways of plant genome engineering.
Contact Details | 123, Uiryodanji-gil, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of KoreaTEL 043-236-2201E-Mail: thanks@gflas.com |
---|
Find out more companies
Related products
-
Venture
Aprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid